Azacitidine
About
Therapy type: Chemotherapy
Therapy strategy: Hypomethylating agent chemotherapy
Mappings
NCI Thesaurus: Azacitidine (coding:ncit:C288)
RxNorm: azacitidine (coding:rxcui:1251, coding:omop:1314865)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | IDH1 p.R132C | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132G | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132H | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132L | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132S | Acute Myeloid Leukemia | Azacitidine, Ivosidenib |